Originally Published as The Niche Podcast
Welcome to a special bonus episode as we kick off Season 2 the Niche Podcast. I sat down with Dr. Jayne Morgan, the head of the COVID19 task force at Piedmont Healthcare to talk about her career in clinical research.
Sponsors
https://www.thescopemethod.com
Dr. Morgan on LinkedIn
https://tinyurl.com/Niche-057-1
Dr. Morgan on Instagram
https://tinyurl.com/Niche-057-2
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
About The Niche Podcast
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Originally Published as The Niche Podcast
Welcome to a special bonus episode as we kick off Season 2 the Niche Podcast. I sat down with Dr. Jayne Morgan, the head of the COVID19 task force at Piedmont Healthcare to talk about her career in clinical research.
Sponsors
https://www.thescopemethod.com
Dr. Morgan on LinkedIn
https://tinyurl.com/Niche-057-1
Dr. Morgan on Instagram
https://tinyurl.com/Niche-057-2
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
About The Niche Podcast
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.